**Question:** Increase in alpha-fetoprotein is seen in:

A. Chronic liver diseases
B. Hepatocellular carcinoma (HCC)
C. Neonatal jaundice
D. Acute liver failure

**Core Concept:**

Alpha-fetoprotein (AFP) is a glycoprotein produced mainly by the yolk sac, fetal liver, and gut during fetal development. It is primarily used as a marker for fetal liver function and is minimally detectable in adult blood. However, in certain pathological conditions, AFP levels can increase in the bloodstream.

**Why the Correct Answer is Right:**

B. Hepatocellular carcinoma (HCC) is a malignant tumor of the liver cells. In HCC, the liver cells are replaced by tumor cells, leading to the overproduction of AFP. As a result, AFP levels increase in the bloodstream.

**Why Each Wrong Option is Incorrect:**

A. Chronic liver diseases like cirrhosis and hepatitis cause liver dysfunction, but AFP production is not directly linked to these conditions. Thus, AFP levels do not increase in chronic liver diseases.

C. Neonatal jaundice is caused by elevated bilirubin levels in the blood, not AFP. Although AFP is slightly elevated in newborns, it is not the primary cause of jaundice in this context.

D. Acute liver failure occurs due to rapid destruction of liver cells, leading to a decrease in AFP levels, not an increase.

**Clinical Pearl:**

Understanding AFP levels can be crucial in diagnosing certain liver-related conditions like hepatocellular carcinoma. However, it is essential to consider the context of each disease process when interpreting AFP levels, as they can be affected by various liver diseases.